MeSH Browser

MeSH Heading: Gastrinoma
Tree Number(s): C04.557.470.200.025.290.500; C04.588.274.761.500.124; C04.588.322.475.500.124; C06.301.761.500.124; C06.689.667.500.124; C19.344.421.500.124
Unique ID: D015408
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D015408
Annotation: coord IM with PANCREATIC NEOPLASMS (IM) or other precoord organ/neopl term (IM) if not in pancreas
Scope Note: A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).
Entry Term(s): Gastrin-Producing Tumor; Islet Cell Tumor, Ulcerogenic; Ulcerogenic Islet Cell Tumor
Previous Indexing: Islet Cell Tumor (1981); Zollinger-Ellison Syndrome (1982-1988)
See Also: Multiple Endocrine Neoplasia Type 1; Zollinger-Ellison Syndrome
Public MeSH Note: 89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981
Online Note: use ZOLLINGER-ELLISON SYNDROME to search GASTRINOMA 1982-88; use ADENOMA, ISLET CELL 1981
History Note: 89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981
Date Established: 1989/01/01
Date of Entry: 1988/06/07
Revision Date: 2013/07/09

Allowable Qualifiers: blood (BL)

blood supply (BS)

cerebrospinal fluid (CF)

chemically induced (CI)

chemistry (CH)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

secondary (SC)

surgery (SU)

therapy (TH)

ultrastructure (UL)

urine (UR)

veterinary (VE)

virology (VI)

Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
  - Neoplasms, Glandular and Epithelial [C04.557.470]
    - Carcinoma [C04.557.470.200]
      - Adenocarcinoma [C04.557.470.200.025]
        
        Carcinoma, Islet Cell [C04.557.470.200.025.290]
        
        Gastrinoma [C04.557.470.200.025.290.500]
        
        Glucagonoma [C04.557.470.200.025.290.750]

Neoplasms [C04]
- Neoplasms by Site [C04.588]
  - Digestive System Neoplasms [C04.588.274]
    - Pancreatic Neoplasms [C04.588.274.761]
      - Carcinoma, Islet Cell [C04.588.274.761.500]
        
        Gastrinoma [C04.588.274.761.500.124]
        
        Glucagonoma [C04.588.274.761.500.249]
        
        Somatostatinoma [C04.588.274.761.500.500]
        
        Vipoma [C04.588.274.761.500.750]

Neoplasms [C04]
- Neoplasms by Site [C04.588]
  - Endocrine Gland Neoplasms [C04.588.322]
    - Pancreatic Neoplasms [C04.588.322.475]
      - Carcinoma, Islet Cell [C04.588.322.475.500]
        
        Gastrinoma [C04.588.322.475.500.124]
        
        Glucagonoma [C04.588.322.475.500.249]
        
        Somatostatinoma [C04.588.322.475.500.500]
        
        Vipoma [C04.588.322.475.500.750]

Digestive System Diseases [C06]
- Digestive System Neoplasms [C06.301]
  - Pancreatic Neoplasms [C06.301.761]
    - Carcinoma, Islet Cell [C06.301.761.500]

Digestive System Diseases [C06]
- Pancreatic Diseases [C06.689]
  - Pancreatic Neoplasms [C06.689.667]
    - Carcinoma, Islet Cell [C06.689.667.500]

Endocrine System Diseases [C19]
- Endocrine Gland Neoplasms [C19.344]
  - Pancreatic Neoplasms [C19.344.421]
    - Carcinoma, Islet Cell [C19.344.421.500]

Gastrinoma Preferred

Concept UI: M0023742
Scope Note: A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).
Terms: Gastrinoma Preferred Term
Term UI T045458
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1989); Gastrin-Producing Tumor
Term UI T045457
Date06/07/1988
LexicalTag NON
ThesaurusID UNK (19XX); Islet Cell Tumor, Ulcerogenic
Term UI T043888
Date03/30/1974
LexicalTag NON
ThesaurusID UNK (19XX); Ulcerogenic Islet Cell Tumor
Term UI T043887
Date05/30/1984
LexicalTag NON
ThesaurusID UNK (19XX)

Gastrinoma MeSH Descriptor Data 2025